Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells

Biswas, 2003, Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis, Hepatology, 38, 1167, 10.1053/jhep.2003.50459

Blanchard, 1986, In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells, Int J Immunopharmacol, 8, 819, 10.1016/0192-0561(86)90020-2

Bonder, 2004, Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis, J Immunol, 172, 45, 10.4049/jimmunol.172.1.45

Center for Drug Evaluation and Research (2002) Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers. Food and Drug Administration, Rockville, MD. Available at: http://www.fda.gov/cber/gdlns/dose.htm

Chan, 1996, Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice, Fundam Appl Toxicol, 30, 109, 10.1006/faat.1996.0048

Chang, 2006, Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms, Br J Pharmacol, 148, 102, 10.1038/sj.bjp.0706699

Chen, 2001, CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death, J Immunol, 166, 5889, 10.4049/jimmunol.166.10.5889

Chisari, 1995, Hepatitis B virus immunopathogenesis, Annu Rev Immunol, 13, 29, 10.1146/annurev.iy.13.040195.000333

Cravatt, 2001, Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase, Proc Natl Acad Sci U S A, 98, 9371, 10.1073/pnas.161191698

Cravatt, 1996, Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature, 384, 83, 10.1038/384083a0

Croxford, 2005, Cannabinoids and the immune system: potential for the treatment of inflammatory diseases?, J Neuroimmunol, 166, 3, 10.1016/j.jneuroim.2005.04.023

Czaja, 2002, Diagnosis and treatment of autoimmune hepatitis, Hepatology, 36, 479, 10.1053/jhep.2002.34944

Devane, 1992, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258, 1946, 10.1126/science.1470919

Do, 2004, Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation, J Immunol, 173, 2373, 10.4049/jimmunol.173.4.2373

Erhardt, 2007, IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice, Hepatology, 45, 475, 10.1002/hep.21498

Fontenot, 2003, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat Immunol, 4, 330, 10.1038/ni904

Furtado, 2002, Interleukin 2 signaling is required for CD4(+) regulatory T cell function, J Exp Med, 196, 851, 10.1084/jem.20020190

Gantner, 1995, Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor, Hepatology, 21, 190

Haeryfar, 2005, Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities, J Immunol, 174, 3344, 10.4049/jimmunol.174.6.3344

Iredale, 1998, Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors, J Clin Invest, 102, 538, 10.1172/JCI1018

Julien, 2005, Antifibrogenic role of the cannabinoid receptor CB2 in the liver, Gastroenterology, 128, 742, 10.1053/j.gastro.2004.12.050

Kamath, 1997, Evidence for the induction of apoptosis in thymocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin in vivo, Toxicol Appl Pharmacol, 142, 367, 10.1006/taap.1996.8049

Karsak, 2007, Attenuation of allergic contact dermatitis through the endocannabinoid system, Science, 316, 1494, 10.1126/science.1142265

Kathuria, 2003, Modulation of anxiety through blockade of anandamide hydrolysis, Nat Med, 9, 76, 10.1038/nm803

Kita, 2001, The lymphoid liver: considerations on pathways to autoimmune injury, Gastroenterology, 120, 1485, 10.1053/gast.2001.22441

Klein, 2000, Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection, J Immunol, 164, 6461, 10.4049/jimmunol.164.12.6461

Küsters, 1996, Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A, Gastroenterology, 111, 462, 10.1053/gast.1996.v111.pm8690213

Louis, 2002, Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice, Gastroenterology, 122, 2001, 10.1053/gast.2002.33620

Mackie, 2006, Cannabinoid receptors as therapeutic targets, Annu Rev Pharmacol Toxicol, 46, 101, 10.1146/annurev.pharmtox.46.120604.141254

Mallat, 2008, Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver, Am J Physiol Gastrointest Liver Physiol, 294, G9, 10.1152/ajpgi.00467.2007

Matias, 2002, Presence and regulation of the endocannabinoid system in human dendritic cells, Eur J Biochem, 269, 3771, 10.1046/j.1432-1033.2002.03078.x

McKallip, 2002, Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo, J Pharmacol Exp Ther, 302, 451, 10.1124/jpet.102.033506

McKallip, 2005, Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response, J Immunol, 174, 3281, 10.4049/jimmunol.174.6.3281

Oakley, 2005, Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis, Gastroenterology, 128, 108, 10.1053/j.gastro.2004.10.003

Osei-Hyiaman, 2005, Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity, J Clin Invest, 115, 1298, 10.1172/JCI200523057

Pacher, 2006, The endocannabinoid system as an emerging target of pharmacotherapy, Pharmacol Rev, 58, 389, 10.1124/pr.58.3.2

Pacher, 2008, Endocannabinoid effects on immune cells: implications for inflammatory liver diseases, Am J Physiol Gastrointest Liver Physiol, 294, G850, 10.1152/ajpgi.00523.2007

Pasare, 2003, Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells, Science, 299, 1033, 10.1126/science.1078231

Pertwee, 2002, Cannabinoids and multiple sclerosis, Pharmacol Ther, 95, 165, 10.1016/S0163-7258(02)00255-3

Quartilho, 2003, Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannabinoid receptors, Anesthesiology, 99, 955, 10.1097/00000542-200310000-00031

Russell, 1995, Activation-induced death of mature T cells in the regulation of immune responses, Curr Opin Immunol, 7, 382, 10.1016/0952-7915(95)80114-6

Schümann, 2000, Importance of Kupffer cells for T-cell-dependent liver injury in mice, Am J Pathol, 157, 1671, 10.1016/S0002-9440(10)64804-3

Siegmund, 2007, The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species, FASEB J, 21, 2798, 10.1096/fj.06-7717com

Siegmund, 2008, Endocannabinoids and Liver Disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis, Am J Physiol Gastrointest Liver Physiol, 294, G357, 10.1152/ajpgi.00456.2007

Siegmund, 2006, Fatty acid amide hydrolase determines anandamide-induced cell death in the liver, J Biol Chem, 281, 10431, 10.1074/jbc.M509706200

Steffens, 2005, Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice, Nature, 434, 782, 10.1038/nature03389

Tagawa, 1997, Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes, J Immunol, 159, 1418, 10.4049/jimmunol.159.3.1418

Takeda, 2000, Critical contribution of liver natural killer T cells to a murine model of hepatitis, Proc Natl Acad Sci U S A, 97, 5498, 10.1073/pnas.040566697

Teixeira-Clerc, 2006, CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis, Nat Med, 12, 671, 10.1038/nm1421

Tiegs, 1992, A T cell-dependent experimental liver injury in mice inducible by concanavalin A, J Clin Invest, 90, 196, 10.1172/JCI115836

Van Sickle, 2005, Identification and functional characterization of brainstem cannabinoid CB2 receptors, Science, 310, 329, 10.1126/science.1115740